FIELD: medicine. SUBSTANCE: method involves intravenously administering blood coagulation factor VIII concentrate to reach its activity level of at least 50% before taking biopsy samples. Hepatic puncture canal is filled with blood coagulation factor VIII concentrate of 250- 500 ED diluted with 3-5 ml of 5% ε-aminocaproic acid. Patient blood coagulation factor VIII activity is supported in postoperative period at the level of not less than 50% during the first three days and of not less than 10% during the next 7 days. EFFECT: enhanced effectiveness of treatment; accelerated thrombus formation in puncture canal.
展开▼
机译:领域:医学。物质:该方法涉及在抽取活检样本之前静脉内给予凝血因子VIII浓缩物以使其活性水平至少达到50%。肝穿刺管中充满用3-5 ml 5%ε-氨基己酸稀释的250-500 ED凝血因子VIII浓缩液。术后患者血液中凝血因子VIII的活性在头三天的支持水平不低于50%,在接下来的7天的支持水平不低于10%。效果:治疗效果增强;穿刺管血栓形成加速。
展开▼